Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and not-for-profits through small and mid-cap biotechnology companies to leading global pharmaceutical companies. Royalty Pharma has assembled a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industry’s leading therapies. Royalty Pharma funds innovation in the biopharmaceutical industry both directly and indirectly - directly when it partners with companies to co-fund late-stage clinical trials and new product launches in exchange for future royalties, and indirectly when it acquires existing royalties from the original innovators. Royalty Pharma’s current portfolio includes royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson’s Imbruvica, Astellas’ and Pfizer’s Xtandi, Biogen’s Tysabri, Johnson & Johnson’s Tremfya, Gilead’s Trodelvy, Merck’s Januvia, Novartis’ Promacta, Vertex’s Kalydeco, Orkambi, Symdeko and Trikafta, and ten development-stage product candidates.
View Top Employees from Royalty PharmaWebsite | http://www.royaltypharma.com |
Ticker | RPRX |
Revenue | $2.2 billion |
Employees | 85 (81 on RocketReach) |
Founded | 1996 |
Address | 110 East 59th street 33rd floor, New York, New York 10022, US |
Phone | (212) 883-0200 |
Fax | (617) 986-4501 |
Technologies |
JavaScript,
HTML,
Google Analytics
+21 more
(view full list)
|
Industry | Biotechnology Research, Venture Capital & Private Equity, Biotechnology, Finance, Science and Engineering, Pharmaceutical, Health Care |
Web Rank | 9 Million |
Keywords | Royalty Pharma, Royalty Pharma., Royalty Pharma Buys Perrigo, Galvus Logo, Alex Perfall |
Competitors | ATP (Apple Tree Partners), HealthCare Royalty Partners, Pappas Capital, Sorenson Capital, Western Technology Investment |
SIC | SIC Code 283 Companies, SIC Code 738 Companies, SIC Code 28 Companies, SIC Code 73 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 52 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 525 Companies |
Looking for a particular Royalty Pharma employee's phone or email?
The Royalty Pharma annual revenue was $2.2 billion in 2024.
81 people are employed at Royalty Pharma.
Royalty Pharma is based in New York, New York.
The NAICS codes for Royalty Pharma are [32541, 32, 52, 3254, 325, 525].
The SIC codes for Royalty Pharma are [283, 738, 28, 73].